TAMPA, Fla., Jan. 24, 2005 (PRIMEZONE) -- Southwestern Medical Solutions, Inc. (Pink Sheets:SWNM) is pleased to announce that, as the final stages of development of Design 1 Labguard(tm) systems nears completion, it has already begun design analysis and discussions with manufacturing to develop its Design 2 Labguard(tm), which will facilitate an even broader array of tests to be conducted with a single device.
Early Market Indications Very Positive
Mr. Gene Warner, owner of several diagnostic testing facilities in the South, has made the following comments regarding Labguard and its impending market launch, "The Labguard(tm) will bring to market a more affordable means of diagnostic testing with advancements that should render many of the current modalities obsolete. This is a simple and safe device and we will implement it into our entire system immediately upon its availability."
During preparations for the launch of this first generation product, SWNM has been in contact with many suppliers to major U.S. and international medical corporations and has been met with open arms. SWNM carried out independent research with hundreds of caregivers, diagnostic testing facilities and large distributors to determine the needs for the stage 1 and stage 2 Labguard(tm) product lines. Due to the increased capabilities of the manufacturing and prototyping processes, the stage 2 product launch will follow the launch of the stage 1 product by only a few short months.
Southwestern Medical Has The Solution
The Company's proprietary Labguard(tm) on-site collection & diagnostic testing technology represents a revolutionary approach that ensures greater safety and convenience for diagnostic testing administrators at an attractive, market-competitive price. Currently in the final prototype stage, Labguard(tm) has attracted expressions of strong interest from several major medical-device distribution companies, both in the U.S. and abroad. Numerous applications of the Labguard(tm) to address specific market needs, such as non-invasive HIV testing, are currently in the design, prototype and/or testing stages. Southwestern Medical is also involved in prototype design and testing of the promising Protect-A-Pal(tm) needle safety device, to which it now owns the world marketing rights.
The statements made in this press release, which are not historical facts, contain forward-looking statements concerning potential developments affecting the business, prospects, financial conditions and other aspects of the company to which this release pertains. The actual results of the specific items described in the release, and the company's operations generally, may differ materially from what is projected in such forward- looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the he company disclaims any obligation to update information contained in any forward- looking statement.